Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.
about
Inhibition of TMEM16A expression suppresses growth and invasion in human colorectal cancer cellsAnalyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review.Pien Tze Huang Inhibits Hypoxia-Induced Angiogenesis via HIF-1 α /VEGF-A Pathway in Colorectal Cancer.Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial.Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.Antiangiogenic therapy for refractory colorectal cancer: current options and future strategies.Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.Dovitinib enhances temozolomide efficacy in glioblastoma cells.Cytotoxic effects of the newly-developed chemotherapeutic agents 17-AAG in combination with oxaliplatin and capecitabine in colorectal cancer cell lines.
P2860
Q28542858-C05EC302-4DF1-40F3-8722-1B293C6E6BA9Q33732199-A6247660-0E14-4C51-A95C-49178030518CQ35026527-55FE36FE-9B3D-4ACE-95AF-08DB7F43E534Q35475535-CCEDD372-115C-41A7-BF3C-A6C03C36415FQ35766292-27258FBE-31B5-481B-8034-B12D4214AF0CQ37632167-93D519D6-E72F-46DB-A5C6-298B5EFC0E2FQ38854734-671408BC-610E-452F-9805-CB869C0AF39BQ40214485-50F954E7-0403-4130-866E-F45CECF29D21Q47106034-CB523CE2-BAC1-4BAA-A7BC-E6402C278F22
P2860
Dovitinib synergizes with oxaliplatin in suppressing cell proliferation and inducing apoptosis in colorectal cancer cells regardless of RAS-RAF mutation status.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@en
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@nl
type
label
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@en
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@nl
prefLabel
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@en
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@nl
P2093
P2860
P356
P1433
P1476
Dovitinib synergizes with oxal ...... ss of RAS-RAF mutation status.
@en
P2093
Her-Shuyong Shia
Linling Chen
Nan Yong Hsu
Shikha Gaur
Vincent Ann
Vincent H S Chang
Wei-Chen Lin
Yafan Wang
P2860
P2888
P356
10.1186/1476-4598-13-21
P577
2014-02-04T00:00:00Z
P5875
P6179
1035773323